{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:00:10Z","timestamp":1790305210006,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,4,25]],"date-time":"2008-04-25T00:00:00Z","timestamp":1209081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2008,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Weight gain is a side effect of glucocorticoid (GC) use, but the natural history and health implications of changes in weight that occur during the treatment of inflammatory disease are not understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We evaluated data from the Wegener's Granulomatosis Etanercept Trial. Patients were categorized according to clinical outcome at 1 year: remission (no disease flares), single flare, or multiple flares. Risk factors for gaining \u226510 kg were examined in multivariate models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Weights at baseline and 1 year were available for 157 (93%) of the 168 patients analyzed. During year 1, the mean cumulative prednisone dosage in the multiple flares subgroup was 7.9 gm, compared with 6.0 gm and 3.9 gm in the single flare and remission subgroups, respectively (<jats:italic>P<\/jats:italic> &lt; 0.001). Patients in these subgroups gained an average of 2.6 kg, 4.1 kg, and 5.8 kg, respectively (<jats:italic>P<\/jats:italic> = 0.005). Weight gain did not correlate with cumulative GC dose (R = 0.10, <jats:italic>P<\/jats:italic> = 0.25). Thirty\u2010five patients (22.3%) gained and maintained \u226510 kg in the first year. New diagnosis of Wegener's granulomatosis at baseline was an independent predictor of gaining \u226510 kg at 1 year (odds ratio 19.7, 95% confidence interval 2.4\u2013162.6, <jats:italic>P<\/jats:italic> = 0.006). Among the 78 patients in the remission subgroup, 40 sustained remissions through the 2\u2010year time point. For these 40 patients, the mean weight gained at year 1 did not regress by the end of year 2, despite the absence of continued GC use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Disease control was associated with lower cumulative GC doses but greater weight gain. More than one\u2010fifth of patients gained &gt;10 kg in the first year of treatment. The quantity of weight gained by patients during treatment has potential future health implications.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.23561","type":"journal-article","created":{"date-parts":[[2008,4,25]],"date-time":"2008-04-25T23:46:19Z","timestamp":1209167179000},"page":"746-753","source":"Crossref","is-referenced-by-count":47,"title":["Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis"],"prefix":"10.1002","volume":"59","author":[{"given":"Peter K.","family":"Wung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Spiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. William","family":"St.Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Joseph","family":"McCune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,4,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2004.12.003"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa023161"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.26279"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-000-0005-0"},{"key":"e_1_2_6_6_2","first-page":"477","article-title":"Management and prognosis of systemic lupus erythematosus","volume":"18","author":"Dubois EL","year":"1967","journal-title":"Bull Rheum Dis"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-6-488"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.1.32"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/93.2.105"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7053.344"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041884"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400222"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21117"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(02)00209-X"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11075"},{"issue":"2","key":"e_1_2_6_18_2","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report","volume":"6","author":"National Institutes of Health","year":"1998","journal-title":"Obes Res"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199303000-00006"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2005.02.003"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/0-387-26283-0_9"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/011542650602100168"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0185"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh321"},{"key":"e_1_2_6_25_2","first-page":"1505","article-title":"Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis: possible association with tumor necrosis factor","volume":"19","author":"Roubenoff R","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_6_26_2","first-page":"23","article-title":"Tumor necrosis factor\u2010alpha production is associated with less body cell mass in women with rheumatoid arthritis","volume":"31","author":"Walsmith J","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.72.12.1105"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01484-5"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03327392"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2002.202"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.2.187"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-108X(200001)27:1<101::AID-EAT12>3.0.CO;2-D"},{"key":"e_1_2_6_33_2","first-page":"1196","article-title":"The impact of obesity on work limitations and cardiovascular risk factors in the U.S. workforce","volume":"46","author":"Hertz RP","year":"2004","journal-title":"J Occup Environ Med"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.89.8.1194"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21984"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401022"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.23561","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.23561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T22:29:43Z","timestamp":1700000983000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.23561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,25]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5,15]]}},"alternative-id":["10.1002\/art.23561"],"URL":"https:\/\/doi.org\/10.1002\/art.23561","archive":["Portico"],"relation":{},"ISSN":["0893-7524","1529-0123"],"issn-type":[{"value":"0893-7524","type":"print"},{"value":"1529-0123","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,25]]}}}